The BRIDGE-DS Study: Improved Glycemic Control and Renal Function in Type 2 Diabetes Mellitus Patients Using the Fixed-Dose Combination of Dapagliflozin and Sitagliptin
Journal of Endocrinology and Metabolism · 2025
DOI: 10.14740/jem1055 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Endocrinology and Metabolism, 2025. Verfasst von Animesh Maiti und 15 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Maiti, A., Pandey, A. K., Kale, S., Mukherjee, T., Biswas, A., Pal, S. K., A, R., Vignesh, J., Navin, R., Nelakuditi, L. K., Gillurkar, C., Bandyopadhyaya, B., Detroja, N., Kesarkar, R. N., Prasad, A., & Pednekar, A. (2025). The BRIDGE-DS Study: Improved Glycemic Control and Renal Function in Type 2 Diabetes Mellitus Patients Using the Fixed-Dose Combination of Dapagliflozin and Sitagliptin. Journal of Endocrinology and Metabolism. https://doi.org/10.14740/jem1055
Vancouver
Maiti A, Pandey AK, Kale S, Mukherjee T, Biswas A, Pal SK, et al. The BRIDGE-DS Study: Improved Glycemic Control and Renal Function in Type 2 Diabetes Mellitus Patients Using the Fixed-Dose Combination of Dapagliflozin and Sitagliptin. Journal of Endocrinology and Metabolism. 2025. doi:10.14740/jem1055
BibTeX
@article{Maiti2025,
author = {Maiti, Animesh and Pandey, Arun Kumar and Kale, Shailja and Mukherjee, Tirthankar and Biswas, Amitabh and Pal, Salil Kumar and A, Ramanan and Vignesh, J.P. and Navin, R. and Nelakuditi, Lakshmana Kumar and Gillurkar, Chandrashekhar and Bandyopadhyaya, Biplab and Detroja, Nilesh and Kesarkar, Rohan Narayan and Prasad, Ashish and Pednekar, Abhijit},
title = {The BRIDGE-DS Study: Improved Glycemic Control and Renal Function in Type 2 Diabetes Mellitus Patients Using the Fixed-Dose Combination of Dapagliflozin and Sitagliptin},
journal = {Journal of Endocrinology and Metabolism},
year = {2025},
doi = {10.14740/jem1055}
}
EUVIMED